American Association for Cancer Research
Browse
00085472can141140-sup-130072_2_supp_2675535_ncfqtp.docx (22.92 kB)

Supplementary Methods, Figure Legends from Targeting of miR34a–NOTCH1 Axis Reduced Breast Cancer Stemness and Chemoresistance

Download (22.92 kB)
journal contribution
posted on 2023-03-30, 22:44 authored by Eun Young Park, EunSun Chang, Eun Ji Lee, Hyun-Woo Lee, Hyeok-Gu Kang, Kyung-Hee Chun, Yu Mi Woo, Hyun Kyung Kong, Je Yeong Ko, Hiromu Suzuki, Erwei Song, Jong Hoon Park

Supplementary Methods, Figure Legends

History

ARTICLE ABSTRACT

Human breast cancers include cancer stem cell populations as well as nontumorigenic cancer cells. Breast cancer stem cells have self-renewal capability and are resistant to conventional chemotherapy. miRNAs regulate the expression of many target genes; therefore, dysregulation of miRNAs has been associated with the pathogenesis of human diseases, including cancer. However, a role for miRNA dysregulation in stemness and drug resistance has yet to be identified. Members of the miR34 family are reportedly tumor-suppressor miRNAs and are associated with various human cancers. Our results confirm that miR34a expression was downregulated in MCF7/ADR cells compared with MCF7 cells. We hypothesized that this reduction was due to the p53 (TP53) mutation in MCF7/ADR cells. In this study, we found that primary and mature miR34a were suppressed by treatment with p53 RNAi or the dominant-negative p53 mutant in MCF7 cells. Ectopic miR34a expression reduced cancer stem cell properties and increased sensitivity to doxorubicin treatment by directly targeting NOTCH1. Furthermore, tumors from nude mice treated with miR34a were significantly smaller compared with those of mice treated with control lentivirus. Our research suggests that the ectopic expression of miR34a represents a novel therapeutic approach in chemoresistant breast cancer treatment. Cancer Res; 74(24); 7573–82. ©2014 AACR.

Usage metrics

    Cancer Research

    Licence

    Exports

    RefWorks
    BibTeX
    Ref. manager
    Endnote
    DataCite
    NLM
    DC